| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784926 | Advances in Radiation Oncology | 2017 | 11 Pages |
Abstract
Trimodality treatment significantly improves survival and FFR in patients with LA-NSCLC when definitive doses of radiation with neoadjuvant chemotherapy are employed. We identified important demographic features that predict the use of surgical intervention in patients with stage III NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Melissa A.L. MD PhD, Neha MD PhD, Whitney M. MD, Michelle NP, Mohan MD MBA, James MD, Elizabeth M. MD, Josephine MD, Søren M. PhD DMSc, Shahed MD, Shamus R. MD, Joseph MD, Charles B. MD, Martin J. MD, Steven J. MD, Pranshu MD,